Automation in the context of stem cell production – where are we heading with Industry 4.0?

In by

Spotlight Article

Expert Insight

Michael Kulik*, Jelena Ochs*, Niels König & Robert Schmitt

Automation: migration from manual processes to closed-system automation

As the field of cell and gene therapy continues to progress, the need for cell products for therapeutic application is increasing. In order to meet the demands, novel challenges particularly within the manufacturing of these products need to be overcome. By translating and applying automation solutions from the production industries into cell culture applications, standardized processing procedures can be introduced in order to reduce the variability, which is a critical issue within the manufacturing workflow. Additionally, the Industry 4.0 philosophy offers a variety of concepts for the design of adaptive processes that address the specific challenges in stem cell production. Novel tools such as data tracking, data analysis and machine learning are enabling technologies that will help support the safe manufacturing of effective products for future cell and gene therapies.

Published: Nov 10 2016
DOI: 10.18609/cgti.2016.060
Citation: Cell Gene Therapy Insights 2016; 2(4), 499-506.

Open access

This content is restricted to registered users. Click here to Register or Login here.